Filtrona acquires Contego Healthcare for 160m pounds

FIL International, the subsidiary of FTSE 250-listed fibre and foam products provider Filtrona has signed an agreement for the acquisition of Contego Healthcare from Maximus Holding II S.Á R.L. and Storey Evans & Company.

FIL International, the subsidiary of FTSE 250-listed fibre and foam products provider Filtrona has signed an agreement for the acquisition of Contego Healthcare from Maximus Holding II S. R.L. and Storey Evans & Company.

The transaction values Contego at approximately £160m on a cash free, debt free basis.

The consideration, which is subject to customary adjustments for net debt and working capital and which will be payable on completion of the transaction, will be funded in part by a placing by way of an accelerated book-build of up to 21,142,613m new ordinary shares, representing 9.99% of Filtrona's current issued share capital excluding treasury shares.

Filtrona said that the balance will be funded from existing debt facilities.

Completion is conditional upon, among other things, clearance from the German competition authorities, which is anticipated to be satisfied by mid-April 2013, the group added.

Contego is a pan-European specialist business, which provides a range of print, packaging and support services to the pharmaceutical and healthcare markets from operational sites across Europe. Its product range includes folding cartons, leaflets, self-adhesive labels and printed foils used in blister packs.

In 2012 on a consolidated basis, Contego generated revenue of £102.7m, earnings before interest, taxation, depreciation and amortisation (EBITDA) of £17.9m and earnings before interest and taxation (EBIT) of £13.9m. As of December 31st, Contego had gross assets of £78.6m.

Commenting on the acquisition, Colin Day, Chief Executive Officer of Filtrona, said: "The acquisition of Contego is a compelling strategic and complementary fit for Filtrona, as the company increasingly looks to leverage the capabilities and skills which it already has across its operating divisions in attractive growth end-markets.

He added: "With a blue-chip customer base, and a proven track record of profitable growth and innovation, Contego step changes Filtrona's position in the pharmaceutical and healthcare markets for our packaging solutions activities. In addition, through leveraging our global commercial and operational resources, there is a real opportunity to geographically expand not only our combined packaging solutions, but also our other essential components to these end-markets."

MF

Recommended

Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Three fast-growing, undervalued UK mid-cap stocks to buy now
Share tips

Three fast-growing, undervalued UK mid-cap stocks to buy now

Professional investor Katen Patel of the JPMorgan Mid Cap Investment Trust picks three fast-growing UK mid-cap stocks to buy now.
18 May 2022
Should you buy Vodafone shares, or steer clear?
Share tips

Should you buy Vodafone shares, or steer clear?

Vodafone grew revenue by 4% and profit by 11% last year, and offers investors a 6.4% dividend yield. So should you buy Vodafone shares? Rupert Hargrea…
17 May 2022

Most Popular

Get set for another debt binge as real interest rates fall
UK Economy

Get set for another debt binge as real interest rates fall

Despite the fuss about rising interest rates, they’re falling in real terms. That will blow up a wild bubble, says Matthew Lynn.
15 May 2022
Is the oil market heading for a supply glut?
Oil

Is the oil market heading for a supply glut?

Many people assume that the high oil price is here to stay – and could well go higher. But we’ve been here before, says Max King. History suggests tha…
16 May 2022
Value is starting to emerge in the markets
Investment strategy

Value is starting to emerge in the markets

If you are looking for long-term value in the markets, some is beginning to emerge, says Merryn Somerset Webb. Indeed, you may soon be able to buy tra…
16 May 2022